Conclusion
Our work is the first to analyze demography of cancer incidence rates relative to the prevalence of CMV seropositivity both in U.S. race/ethnic groups and worldwide. A biological connection between the ubiquity of CMV and the incidence of neoplasms is predicated by a worldwide correlation between the two. This result may further inspire an oncologic initiative for development of the CMV-based antitumor vaccine constructs that could result in a significant reduction of human cancers the world over. Here, we aimed at just this.